Correction to: Onset and Relapse of Juvenile Dermatomyositis Following Asymptomatic SARS-CoV-2 Infection

Affiliations

• ¹ Chimie & Biologie, Modélisation et Immunologie pour la Thérapie (CBMIT), Université Paris Descartes, CNRS, UMR8601, Paris, France.
• ² Infectious Diseases Epidemiology and Analytics Unit, Department of Global Health, Institut Pasteur, Paris, France.
• ³ Department of Dermatology, Université de Paris AP-HP-5, Necker-Enfants Malades Hospital, Paris, France.
• ⁴ Translational Immunology Lab, Institut, Pasteur, Paris, France.
• ⁵ Laboratory of Neurogenetics and Neuroinflammation, Imagine, Institute, Paris University, Paris, France.
• ⁶ General Paediatrics, Department of Infectious Disease and Internal, Medicine, Reference Centre for Rheumatic, AutoImmune and Systemic diseases in children (RAISE), Robert Debré, HospitalParis, AP-HP, France.
• ⁷ Department of Paediatric Hematology-Immunology and Rheumatology, Necker-Enfants Malades Hospital, AP-HP, Paris, France, Reference center for Rheumatic, AutoImmune and Systemic diseases in children (RAISE), Paris, France.
• ⁸ Department of Paediatric Hematology-Immunology and Rheumatology, Necker-Enfants Malades Hospital, AP-HP, Paris, France, Reference center for Rheumatic, AutoImmune and Systemic diseases in children (RAISE), Paris, France. brigitte.bader-meunier@aphp.fr.
• ⁹ Laboratory of Immunogenetics of Paediatric Autoimmunity, Imagine Institute, Inserm U 1163, Paris University, Paris, France. brigitte.bader-meunier@aphp.fr.